Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70:375–403.

Article  PubMed  PubMed Central  Google Scholar 

Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47–52.

Article  CAS  PubMed  Google Scholar 

Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131–42.

Article  CAS  PubMed  Google Scholar 

Wang J, Dumartin L, Mafficini A, Ulug P, Sangaralingam A, Alamiry NA, et al. Splice variants as novel targets in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:2980.

Article  PubMed  PubMed Central  Google Scholar 

Escobar-Hoyos LF, Penson A, Kannan R, Cho H, Pan CH, Singh RK, et al. Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell. 2020;38:198–211.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jbara A, Lin KT, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, et al. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Nature. 2023;617:147–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan L, Lin KT, Rahman MA, Ishigami Y, Wang Z, Jensen MA, et al. Splicing factor SRSF1 promotes pancreatitis and KRASG12D-mediated pancreatic cancer. Cancer Discov. 2023;13:1678–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alors-Pérez E, Pedraza-Arevalo S, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Berbel I, et al. Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. J Exp Clin Cancer Res. 2023;42:282.

Article  PubMed  PubMed Central  Google Scholar 

Alors-Perez E, Blázquez-Encinas R, Alcalá S, Viyuela-García C, Pedraza-Arevalo S, Herrero-Aguayo V, et al. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. J Exp Clin Cancer Res. 2021;40:382.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marasco LE, Kornblihtt AR. The physiology of alternative splicing. Nat Rev Mol Cell Biol. 2023;24:242–54.

Article  CAS  PubMed  Google Scholar 

Wright CJ, Smith CWJ, Jiggins CD. Alternative splicing as a source of phenotypic diversity. Nat Rev Genet. 2022;23:697–710.

Article  CAS  PubMed  Google Scholar 

Bradley RK, Anczuków O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang E, Aifantis I. RNA splicing and cancer. Trends Cancer. 2020;6:631–44.

Article  CAS  PubMed  Google Scholar 

Wolin SL, Maquat LE. Cellular RNA surveillance in health and disease. Science. 2019;366:822–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye J, She X, Liu Z, He Z, Gao X, Lu L, et al. Eukaryotic initiation factor 4A-3: a review of its physiological role and involvement in oncogenesis. Front Oncol. 2021;11:712045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woodward LA, Mabin JW, Gangras P, Singh G. The exon junction complex: a lifelong guardian of mRNA fate. Wiley Interdiscip Rev RNA. 2017;8:e1411.

Article  Google Scholar 

Xue C, Gu X, Li G, Bao Z, Li L. Expression and functional roles of eukaryotic initiation factor 4A family proteins in human cancers. Front Cell Dev Biol. 2021;9:711965.

Article  PubMed  PubMed Central  Google Scholar 

Gehring NH, Kunz JB, Neu-Yilik G, Breit S, Viegas MH, Hentze MW, et al. Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol Cell. 2005;20:65–75.

Article  CAS  PubMed  Google Scholar 

Kanellis DC, Espinoza JA, Zisi A, Sakkas E, Bartkova J, Katsori AM, et al. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Sci Adv. 2021;7:eabf7561.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Ren S, Xia J, Wei Y, Xi Y. EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3. Mol Ther Nucleic Acids. 2020;19:533–45.

Article  CAS  PubMed  Google Scholar 

Müller D, Shin S, Goullet de Rugy T, Samain R, Baer R, Strehaiano M, et al. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. JCI Insight. 2019;4:e121951.

Chan K, Robert F, Oertlin C, Kapeller-Libermann D, Avizonis D, Gutierrez J, et al. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Nat Commun. 2019;10:5151.

Article  PubMed  PubMed Central  Google Scholar 

Singh K, Lin J, Lecomte N, Mohan P, Gokce A, Sanghvi VR, et al. Targeting eIF4A dependent translation of KRAS signaling molecules. Cancer Res. 2021;81:2002–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Lei C, Lu C, Wang J, Gao M, Gao W. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis. 2019;10:698.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Q, Zhu Z, Xiao W, Zong G, Wang C, Jiang W, et al. Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. Exp Mol Med. 2022;54:1940–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H, Zhong RQ. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer. Biochem Biophys Res Commun. 2005;330:526–32.

Article  CAS  PubMed  Google Scholar 

López-Cánovas JL, Hermán-Sánchez N, Moreno-Montilla MT, Del Rio-Moreno M, Alors-Perez E, Sánchez-Frias ME, et al. Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. Clin Transl Med. 2022;12:e1102.

Article  PubMed  PubMed Central